Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BBNX Beta Bionics, Inc.

休市中 10-23 16:00:00 EDT

19.16

-0.18

-0.93%

盘后19.16

+0.000.00%

19:30 EDT

最高19.54	最低18.81	成交量82.78万
今开19.38	昨收19.34	日振幅3.79%
总市值8.54亿	流通市值5.08亿	总股本4,456万
成交额1,585万	换手率3.12%	流通股本2,652万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":19.16,"timestamp":1792785600000,"preClose":19.34,"halted":0,"volume":827848,"hourTrading":{"tag":"盘后","latestPrice":19.16,"preClose":19.16,"latestTime":"19:30 EDT","volume":1490,"amount":28556.8,"timestamp":1792798204619,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.009307135470527389,"floatShares":26515200,"shares":44561695,"eps":-1.64865,"marketStatus":"休市中","change":-0.18,"latestTime":"10-23 16:00:00 EDT","open":19.38,"high":19.54,"low":18.8075,"amount":15850343.716816,"amplitude":0.037875,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.64865,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":19.34,"preHourTrading":{"tag":"盘前","latestPrice":19,"preClose":19.34,"latestTime":"09:22 EDT","volume":817,"amount":15720.658443999999,"timestamp":1792761744203,"change":-0.34,"changeRate":-0.01758,"amplitude":0.138056},"postHourTrading":{"tag":"盘后","latestPrice":19.16,"preClose":19.16,"latestTime":"19:30 EDT","volume":1490,"amount":28556.8,"timestamp":1792798204619,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8071505608743644,"impliedVol":0.2964,"impliedVolPercentile":0.0294},"requestUrl":"/m/hq/s/BBNX/tweets","defaultTab":"tweets","newsList":[{"id":"1136021484","title":"Beta Bionics宣布将Ilet®仿生胰腺与Mint™整合至Senseonics的Eversense® 365平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1136021484","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136021484?lang=zh_cn&edition=full","pubTime":"2026-09-22 19:36","pubTimestamp":1790076999,"startTime":"0","endTime":"0","summary":"Beta Bionics宣布与Senseonics达成合作协议，将Ilet仿生胰腺和Mint技术与Eversense 365实现整合。这一举措标志着糖尿病管理技术领域的又一重要进展。根据协议，Beta Bionics的Ilet仿生胰腺及Mint系统将与Senseonics的Eversense 365持续血糖监测平台进行无缝对接。Beta Bionics公司方面表示，此次合作是公司致力于开发创新糖尿病解决方案的重要一步。Senseonics作为长期植入式血糖监测技术的先驱，其Eversense 365平台已获得监管机构批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126087260","title":"Beta Bionics重磅宣布：Mint™贴片泵获FDA批准上市，3D Intelligence™胰岛素给药算法同步亮相","url":"https://stock-news.laohu8.com/highlight/detail?id=1126087260","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126087260?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:31","pubTimestamp":1789385470,"startTime":"0","endTime":"0","summary":"Beta Bionics今日对外宣布，其革命性产品Mint贴片泵已正式获得美国食品药品监督管理局的批准。这标志着该公司在糖尿病管理设备领域迈出了关键性的一步。与此同时，公司还揭开了下一代胰岛素给药算法——3D Intelligence的神秘面纱。Mint贴片泵的获批，无疑为胰岛素依赖型患者带来了全新的治疗选择。而3D Intelligence算法的发布，则进一步彰显了Beta Bionics在数字化医疗创新上的雄心。这两项进展的叠加，或将在糖尿病护理领域引发新一轮的技术变革。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146150046","title":"Senseonics Holdings：Eversense 365与iLet整合开发预计2026年第四季度完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1146150046","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146150046?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:03","pubTimestamp":1789383812,"startTime":"0","endTime":"0","summary":"Senseonics Holdings宣布，其Eversense 365与iLet系统的整合开发工作，预计将于2026年第四季度圆满收官。这一时间表的确认，标志着公司在推进连续血糖监测技术与胰岛素输送系统深度融合的进程中，迈出了坚实而关键的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082","SENS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173059523","title":"Senseonics宣布与Beta Bionics达成战略合作，将Eversense® 365整合至Ilet®仿生胰腺系统","url":"https://stock-news.laohu8.com/highlight/detail?id=1173059523","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173059523?lang=zh_cn&edition=full","pubTime":"2026-09-14 19:01","pubTimestamp":1789383686,"startTime":"0","endTime":"0","summary":"Senseonics Holdings, Inc.今日正式宣布，已与Beta Bionics, Inc.达成一项战略合作伙伴关系。双方将携手推进连续血糖监测技术与智能胰岛素输送系统的深度融合，具体而言，Senseonics旗下创新产品Eversense 365传感器将被整合进Beta Bionics研发的Ilet仿生胰腺平台。Senseonics首席执行官在声明中表示，与Beta Bionics的合作将充分发挥各自技术优势，推动个性化糖尿病护理迈向新台阶。Beta Bionics方面亦强调，Eversense 365的长期监测能力与Ilet系统的自适应算法相结合，有望显著提升血糖控制效果，并改善患者的生活质量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","SENS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513777845","title":"Beta Bionics(BBNX.US)获Stifel首次覆盖，给予买入评级, 目标价25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513777845","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513777845?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:21","pubTimestamp":1740410466,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Stifel首次覆盖，给予买入评级, 目标价25.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24232148353170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513722329","title":"Beta Bionics(BBNX.US)获Lake Street首次覆盖，给予买入评级, 目标价30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722329","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513722329?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:22","pubTimestamp":1740406925,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Lake Street首次覆盖，给予买入评级, 目标价30.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24222248352806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513272995","title":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖，给予增持评级, 目标价26.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513272995","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513272995?lang=zh_cn&edition=full","pubTime":"2025-02-24 21:21","pubTimestamp":1740403316,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖，给予增持评级, 目标价26.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24212148352460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513723151","title":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖，给予优于大市评级, 目标价28.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723151","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513723151?lang=zh_cn&edition=full","pubTime":"2025-02-24 20:20","pubTimestamp":1740399654,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖，给予优于大市评级, 目标价28.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24202048351403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.betabionics.com","stockEarnings":[{"period":"1week","weight":0.1719},{"period":"1month","weight":-0.1365},{"period":"3month","weight":0.2088},{"period":"6month","weight":0.7153},{"period":"1year","weight":-0.0427},{"period":"ytd","weight":-0.3712}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0645},{"period":"1year","weight":0.1313},{"period":"ytd","weight":0.1145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Beta Bionics, Inc.于2015年10月21日作为马萨诸塞州福利公司注册成立，并于2024年8月转换为特拉华州公司。公司是一家商业化阶段的医疗器械公司，从事创新解决方案的设计、开发和商业化，通过利用先进的自适应闭环算法简化和改善其疾病的治疗，提高胰岛素需求糖尿病患者的健康和生活质量。","exchange":"NASDAQ","name":"Beta Bionics, Inc.","nameEN":"Beta Bionics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Beta Bionics, Inc.(BBNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Beta Bionics, Inc.,BBNX,Beta Bionics, Inc.股票,Beta Bionics, Inc.股票老虎,Beta Bionics, Inc.股票老虎国际,Beta Bionics, Inc.行情,Beta Bionics, Inc.股票行情,Beta Bionics, Inc.股价,Beta Bionics, Inc.股市,Beta Bionics, Inc.股票价格,Beta Bionics, Inc.股票交易,Beta Bionics, Inc.股票购买,Beta Bionics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Beta Bionics, Inc.(BBNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}